BENTLEY PHARMACEUTICALS' NEWLY FORMED IRISH SUBSIDIARY RECEIVES ITS FIRST MARKETING APPROVAL

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe today announced that its newly formed Irish subsidiary, Bentley Pharmaceuticals Ireland Limited has received approval from the Irish Medicines Board to market 10 mg., 20 mg., and 40 mg. capsules of generic omeprazole in Ireland. Omeprazole belongs to a class of proton-pump inhibitors used in the treatment of acid-related gastrointestinal disorders.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051121005177&newsLang=en)